Whole‑exome evolutionary profiling of osteosarcoma uncovers metastasis‑related driver mutations and generates an independently validated predictive classifier
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals key mutations driving osteosarcoma metastasis and develops a classifier for early detection. ATRX mutations are early events that promote tumor spread and metastasis.
Area Of Science
- Genomics
- Cancer Biology
- Evolutionary Medicine
Background
- Osteosarcoma is a common primary bone cancer with high metastatic potential and poor prognosis.
- Limited understanding of osteosarcoma tumor heterogeneity and evolution hinders effective treatment.
Purpose Of The Study
- To delineate the evolutionary landscape of osteosarcoma metastasis.
- To develop a metastasis prediction model for early diagnosis and risk assessment.
Main Methods
- Whole-exome evolutionary profiling of 61 osteosarcoma cases from the TARGET database.
- Reconstruction of subclonal architectures and differential mutation analysis.
- Development and validation of a metastasis-prediction classifier using causal inference.
Main Results
- Identified a linear evolutionary trajectory in 62% of patients with sequential clonal expansion.
- Discovered eight key mutations associated with metastatic progression.
- Developed a classifier with 83% accuracy, highlighting early ATRX mutations' role in metastasis.
Conclusions
- Delineated the dynamic evolutionary landscape of osteosarcoma metastasis.
- Constructed an early metastasis classification model.
- Highlighted the impact of early ATRX mutations on metastasis initiation, offering diagnostic and risk assessment potential.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...